Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 28% ± 13% | |
microglial cell | 11 studies | 40% ± 15% | |
fibroblast | 11 studies | 22% ± 5% | |
astrocyte | 9 studies | 26% ± 10% | |
macrophage | 9 studies | 26% ± 12% | |
adipocyte | 8 studies | 33% ± 7% | |
glutamatergic neuron | 6 studies | 38% ± 18% | |
epithelial cell | 6 studies | 26% ± 10% | |
GABAergic neuron | 6 studies | 32% ± 15% | |
endothelial cell of lymphatic vessel | 5 studies | 20% ± 4% | |
smooth muscle cell | 5 studies | 20% ± 2% | |
neuron | 4 studies | 21% ± 8% | |
oligodendrocyte precursor cell | 4 studies | 34% ± 13% | |
lymphocyte | 4 studies | 28% ± 11% | |
endothelial cell of artery | 4 studies | 18% ± 2% | |
monocyte | 4 studies | 19% ± 3% | |
pericyte | 4 studies | 23% ± 8% | |
interneuron | 4 studies | 42% ± 18% | |
oligodendrocyte | 4 studies | 25% ± 8% | |
T cell | 3 studies | 27% ± 13% | |
dendritic cell | 3 studies | 19% ± 5% | |
myeloid cell | 3 studies | 23% ± 4% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 20% ± 1% | |
muscle cell | 3 studies | 22% ± 8% | |
alveolar macrophage | 3 studies | 30% ± 11% | |
mast cell | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 30% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9471.37 | 1445 / 1445 | 100% | 76.87 | 183 / 183 |
prostate | 100% | 8073.99 | 245 / 245 | 100% | 53.92 | 502 / 502 |
skin | 100% | 9403.87 | 1809 / 1809 | 100% | 71.55 | 472 / 472 |
ovary | 100% | 9832.76 | 180 / 180 | 100% | 78.14 | 429 / 430 |
thymus | 100% | 7808.08 | 652 / 653 | 100% | 51.68 | 602 / 605 |
breast | 100% | 9372.26 | 459 / 459 | 99% | 54.54 | 1110 / 1118 |
intestine | 100% | 8067.51 | 965 / 966 | 99% | 46.31 | 523 / 527 |
lung | 100% | 9740.65 | 577 / 578 | 99% | 53.40 | 1143 / 1155 |
uterus | 100% | 12012.73 | 170 / 170 | 98% | 46.21 | 452 / 459 |
bladder | 100% | 8779.62 | 21 / 21 | 98% | 39.77 | 495 / 504 |
stomach | 99% | 5257.89 | 354 / 359 | 99% | 55.47 | 284 / 286 |
brain | 98% | 9469.66 | 2590 / 2642 | 100% | 71.80 | 703 / 705 |
kidney | 98% | 4270.08 | 87 / 89 | 95% | 43.98 | 860 / 901 |
adrenal gland | 100% | 3855.03 | 258 / 258 | 88% | 25.19 | 203 / 230 |
liver | 99% | 3542.46 | 224 / 226 | 87% | 21.22 | 354 / 406 |
pancreas | 69% | 1714.22 | 225 / 328 | 98% | 47.33 | 174 / 178 |
adipose | 100% | 10549.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 18168.96 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 50.19 | 80 / 80 |
spleen | 100% | 6474.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 46.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.57 | 1 / 1 |
heart | 99% | 5545.74 | 851 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 3488.50 | 776 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 66% | 16.16 | 19 / 29 |
peripheral blood | 63% | 1844.51 | 582 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048870 | Biological process | cell motility |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0009948 | Biological process | anterior/posterior axis specification |
GO_0060349 | Biological process | bone morphogenesis |
GO_0060392 | Biological process | negative regulation of SMAD protein signal transduction |
GO_0048147 | Biological process | negative regulation of fibroblast proliferation |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0043585 | Biological process | nose morphogenesis |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0048741 | Biological process | skeletal muscle fiber development |
GO_0014902 | Biological process | myotube differentiation |
GO_0060041 | Biological process | retina development in camera-type eye |
GO_0010626 | Biological process | negative regulation of Schwann cell proliferation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0032926 | Biological process | negative regulation of activin receptor signaling pathway |
GO_0021772 | Biological process | olfactory bulb development |
GO_0022011 | Biological process | myelination in peripheral nervous system |
GO_0060038 | Biological process | cardiac muscle cell proliferation |
GO_0060021 | Biological process | roof of mouth development |
GO_0030326 | Biological process | embryonic limb morphogenesis |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0001843 | Biological process | neural tube closure |
GO_0043388 | Biological process | positive regulation of DNA binding |
GO_0043010 | Biological process | camera-type eye development |
GO_0002089 | Biological process | lens morphogenesis in camera-type eye |
GO_0060325 | Biological process | face morphogenesis |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0016604 | Cellular component | nuclear body |
GO_0016605 | Cellular component | PML body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0019901 | Molecular function | protein kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0046332 | Molecular function | SMAD binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0046811 | Molecular function | histone deacetylase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SKI |
Protein name | Ski oncoprotein Ski oncogene (Proto-oncogene c-Ski) |
Synonyms | |
Description | FUNCTION: May play a role in terminal differentiation of skeletal muscle cells but not in the determination of cells to the myogenic lineage. Functions as a repressor of TGF-beta signaling. . |
Accessions | Q7Z459 Q7Z462 Q7Z461 P12755 ENST00000378536.5 |